Immune modulation via T regulatory cell enhancement: Disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases-An EAACI position paper of the Task Force on Immunopharmacology (TIPCO) (2021)
Attributed to:
MICA: Korea-UK PRISM consortium: Establishing Precision Medicine in severe asthma
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/all.14478
PubMed Identifier: 32593226
Publication URI: http://europepmc.org/abstract/MED/32593226
Type: Journal Article/Review
Parent Publication: Allergy
Issue: 1
ISSN: 0105-4538